Atlas Trials

Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00687674 · TERMINATED

Trial details

NCT number
NCT00687674
Sponsor
Mayo Clinic
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma and Plasma Cell Neoplasm
Start date
2008-08-01
Primary completion
2011-11-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.